June 22 - 25 I Booth #571 Anaheim Convention Center, Anaheim, CA
At Philips, we deliver advanced molecular imaging solutions that help you to seamlessly connect data, technology and people across the care continuum. Because today health knows no bounds, and neither should healthcare.
Let’s work together to advance healthcare.
Thank you for joining us during SNMMI for our exclusive event
The Future of AI in Molecular Imaging
Featuring presentations by special guest speakers:
Professor Eliot Siegel, University of Maryland
Michael V. Knopp, MD, PhD, The Ohio State University Wexner Medical Center
Nagara Tamaki, MD, PhD, Department of Radiology, Kyoto Prefectural University of Medicine
Keiichi Magota, PhD, Division of Medical Imaging and Technology, Hokkaido University Hospital
Dr. Jay Kikut, Director of the Department of Nuclear Medicine and PET at the University of Vermont Medical Center, discusses the benefits of Philips Vereos Digital PET/CT scanner and how improved small lesion detectability, fast scanning and low PET dose impacts patient care.
Seamlessly connecting technology and data to empower the people behind the image
Better health outcomes
Supported by rigorous clinical evidence, Vereos is the world’s first and only fully digital, clinically proven, PET/CT solution. Vereos offers improved detectability and characterization of small lesions1 and uncompromised lesion detectability in one tenth of the time2.
Ease the patient experience while facilitating excellent clinical conditions during each procedural step of the imaging exam with Ambient Experience. Dynamic lighting, projection, and sound provide a positive distraction for patients.
The latest edition of Philips' comprehensive advanced visualization and analysis platform, IntelliSpace Portal 10, provides enterprise-wide access to a comprehensive suite of Molecular Imaging processing and review applications.
1 Nguyen NC, Image Quality and Diagnostic Performance of a Digital PET Prototype in Patients with Oncologic Diseases: Initial Experience and Comparison with Analog PET, J Nucl Med 2015; 56:1378–1385
2 Zhang J., Evaluation of speed of PET acquisition: How fast can we go? - A validation of list mode PET simulation approach with true acquisitions, SNMMI 2017
By clicking on the link, you will be leaving the official Royal Philips Healthcare ("Philips") website. Any links to third-party websites that may appear on this site are provided only for your convenience and in no way represent any affiliation or endorsement of the information provided on those linked websites. Philips makes no representations or warranties of any kind with regard to any third-party websites or the information contained therein.